Literature DB >> 26096924

Bone Geometry, Volumetric Density, Microarchitecture, and Estimated Bone Strength Assessed by HR-pQCT in Adult Patients With Type 1 Diabetes Mellitus.

Vikram V Shanbhogue1,2, Stinus Hansen1,2, Morten Frost1,2, Niklas Rye Jørgensen2,3, Anne Pernille Hermann1,2, Jan Erik Henriksen1,2, Kim Brixen1,2.   

Abstract

The primary goal of this cross-sectional in vivo study was to assess peripheral bone microarchitecture, bone strength, and bone remodeling in adult type 1 diabetes (T1D) patients with and without diabetic microvascular disease (MVD+ and MVD-, respectively) and to compare them with age-, gender-, and height-matched healthy control subjects (CoMVD+ and CoMVD-, respectively). The secondary goal was to assess differences in MVD- and MVD+ patients. Fifty-five patients with T1DM (MVD+ group: n = 29) were recruited from the Funen Diabetes Database. Dual-energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT) of the ultradistal radius and tibia, and biochemical markers of bone turnover were performed in all participants. There were no significant differences in HR-pQCT parameters between MVD- and CoMVD- subjects. In contrast, MVD+ patients had larger total and trabecular bone areas (p = 0.04 and p = 0.02, respectively), lower total, trabecular, and cortical volumetric bone mineral density (vBMD) (p < 0.01, p < 0.04, and p < 0.02, respectively), and thinner cortex (p = 0.03) at the radius, and lower total and trabecular vBMD (p = 0.01 and p = 0.02, respectively) at the tibia in comparison to CoMVD+. MVD+ patients also exhibited lower total and trabecular vBMD (radius p = 0.01, tibia p < 0.01), trabecular thickness (radius p = 0.01), estimated bone strength, and greater trabecular separation (radius p = 0.01, tibia p < 0.01) and network inhomogeneity (radius p = 0.01, tibia p < 0.01) in comparison to MVD- patients. These differences remained significant after adjustment for age, body mass index, gender, disease duration, and glycemic control (average glycated hemoglobin over the previous 3 years). Although biochemical markers of bone turnover were significantly lower in MVD+ and MVD- groups in comparison to controls, they were similar between the MVD+ and MVD- groups. The results of our study suggest that the presence of MVD was associated with deficits in cortical and trabecular bone vBMD and microarchitecture that could partly explain the excess skeletal fragility observed in these patients.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE MICROARCHITECTURE; HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; MICROVASCULAR DISEASE; TYPE 1 DIABETES MELLITUS

Mesh:

Year:  2015        PMID: 26096924     DOI: 10.1002/jbmr.2573

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  47 in total

1.  Elevated HbA1c Is Associated with Altered Cortical and Trabecular Microarchitecture in Girls with Type 1 Diabetes.

Authors:  Deborah M Mitchell; Signe Caksa; Taïsha Joseph; Mary L Bouxsein; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 2.  Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.

Authors:  V N Shah; K K Harrall; C S Shah; T L Gallo; P Joshee; J K Snell-Bergeon; W M Kohrt
Journal:  Osteoporos Int       Date:  2017-06-03       Impact factor: 4.507

Review 3.  Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

Authors:  Hillary A Keenan; Ernesto Maddaloni
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 4.  Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Eleanor P Thong; Madhuni Herath; David R Weber; Sanjeeva Ranasinha; Peter R Ebeling; Frances Milat; Helena Teede
Journal:  Clin Endocrinol (Oxf)       Date:  2018-07-03       Impact factor: 3.478

Review 5.  Bone health in type 1 diabetes.

Authors:  Viral N Shah; R Dana Carpenter; Virginia L Ferguson; Ann V Schwartz
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-08       Impact factor: 3.243

Review 6.  Epidemiology of Skeletal Health in Type 1 Diabetes.

Authors:  David R Weber; George Schwartz
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 7.  Growth in patients with type 1 diabetes.

Authors:  Deborah M Mitchell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

8.  Pulsed electromagnetic fields preserve bone architecture and mechanical properties and stimulate porous implant osseointegration by promoting bone anabolism in type 1 diabetic rabbits.

Authors:  J Cai; W Li; T Sun; X Li; E Luo; D Jing
Journal:  Osteoporos Int       Date:  2018-03-09       Impact factor: 4.507

Review 9.  In vivo evaluation of bone microstructure in humans: Clinically useful?

Authors:  Roland Chapurlat
Journal:  Bonekey Rep       Date:  2016-06-15

Review 10.  Determinants of bone strength and quality in diabetes mellitus in humans.

Authors:  Joshua N Farr; Sundeep Khosla
Journal:  Bone       Date:  2015-07-26       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.